Rigel Pharmaceuticals (RIGL) Change in Acquisitions & Divestments (2010 - 2026)

Rigel Pharmaceuticals' Change in Acquisitions & Divestments history runs 17 years deep, the most recent figure standing at $15.9 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 43.65% year-over-year to $15.9 million; the TTM figure through Mar 2026 stood at $66.0 million (up 55.05% YoY), while the FY2025 annual figure was $61.1 million, up 53.98% from the prior year.
• Change in Acquisitions & Divestments was $15.9 million for Q1 2026 at Rigel Pharmaceuticals, up from $13.5 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $29.8 million in Q1 2022 to a low of $6.0 million in Q4 2023.
• Historically, Change in Acquisitions & Divestments has averaged $15.3 million across 5 years, with a median of $15.6 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments soared 2002.72% in 2022, then slumped 71.95% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $21.2 million in 2022, then tumbled by 71.65% to $6.0 million in 2023, then rose by 12.5% to $6.8 million in 2024, then soared by 100.73% to $13.5 million in 2025, then advanced by 17.68% to $15.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $15.9 million (Q1 2026), $13.5 million (Q4 2025), and $20.7 million (Q3 2025), per Business Quant data.